Non–beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma

Propranolol and atenolol, current therapies for problematic infantile hemangioma (IH), are composed of R(+) and S(–) enantiomers: the R(+) enantiomer is largely devoid of beta blocker activity. We investigated the effect of R(+) enantiomers of propranolol and atenolol on the formation of IH-like blo...

Descripción completa

Detalles Bibliográficos
Autores principales: Seebauer, Caroline T., Graus, Matthew S., Lan Huang, McCann, Alex, Wylie-Sears, Jill, Fontaine, Frank, Karnezis, Tara, Zurakowski, David, Staffa, Steven J., Meunier, Frédéric, Mulliken, John B., Bischoff, Joyce, Francois, Mathias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803322/
https://www.ncbi.nlm.nih.gov/pubmed/34874911
http://dx.doi.org/10.1172/JCI151109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803322/
https://www.ncbi.nlm.nih.gov/pubmed/34874911
http://dx.doi.org/10.1172/JCI151109

Ejemplares similares